Login to Your Account



Financings Roundup


Wednesday, January 5, 2011
DARA BioSciences Inc., of Raleigh, N.C., said net proceeds of a recent registered public offering of shares of Series A convertible preferred stock and warrants to purchase shares of common stock will be approximately $4.3 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription